Bartram Richard 4
4 · Esperion Therapeutics, Inc. · Filed Jun 30, 2021
Insider Transaction Report
Form 4
Bartram Richard
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2021-06-28+37,500→ 37,500 totalExercise: $22.52Exp: 2031-06-28→ Common Stock (37,500 underlying) - Award
Performance-based Restricted Stock Units
2021-06-28+26,400→ 26,400 totalExp: 2023-06-30→ Common Stock (26,400 underlying)
Footnotes (3)
- [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be October 15, 2021.
- [F2]Each Performance-Based Restricted Stock Unit represents a contingent right to receive one share of Esperion Therapeutics, Inc. common stock.
- [F3]These shares were issued in connection with a reward of performance-based restricted stock units that will vest only if performance goals are achieved over a two-year period beginning July 1, 2021. The actual number of units (if any) received under this award will depend on continued employment and actual performance over the two-year performance period.